Literature DB >> 35969403

Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type.

Tamara Dörr1, Sabine Haller1, Maja F Müller2, Andrée Friedl3, Danielle Vuichard4,5, Christian R Kahlert1,6, Philipp Kohler1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35969403      PMCID: PMC9379739          DOI: 10.1001/jamanetworkopen.2022.26816

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Health care workers (HCWs) are at increased risk for acquiring SARS-CoV-2 infection,[1] raising the issue of adequate protective measures. Although scientific evidence regarding the benefit of respirator vs surgical masks is sparse,[2,3] a previous study has suggested that respirator masks (ie, FFP2) may offer additional protection to HCW with frequent COVID-19-patient exposure.[4] In this follow-up study, we analyzed the SARS-CoV-2 risk for HCWs depending on cumulative exposure to patients with COVID-19 and assessed whether this risk can be modulated by the use of respirator compared with surgical masks.

Methods

This cohort study was approved by the ethics committee of Eastern Switzerland. Written informed consent was obtained from participants. The study included volunteer HCWs from 7 health care networks in Northern and Eastern Switzerland.[5] Baseline data (collected in September 2020) included anthropometric characteristics and job descriptions. In weekly follow-up evaluations during 12 months, participants indicated results of symptom-based SARS-CoV-2 nasopharyngeal swabs, exposures, and risk behavior (eMethods and eTable in the Supplement). In September 2021, participants indicated which mask type they had used in contact (if any) with patients with COVID-19 in the last 12 months outside of aerosol-generating procedures (among surgical mask only, both mask types, and respirators only). To assess cumulative patient exposure, we multiplied self-reported number of contacts with patients with COVID-19 (range, 0-100) and mean contact duration (range, 1-60 minutes). Cumulative patient exposure was grouped into 8 categories defined by powers of 2. At baseline, in January and September 2021, participants were screened for antinucleocapsid antibodies.[5] The main outcome was SARS-CoV-2 infection during follow-up, ie, self-reported positive nasopharyngeal swab and/or antinucleocapsid seroconversion from baseline. Odds ratios (ORs) for the increase in SARS-CoV-2 positivity per doubling of contact time were calculated separately for HCWs using respirator masks only and those who used only surgical or both mask types. We used logistic regression to adjust for a priori–defined covariables and included networks as random effects (eMethods and eTable in the Supplement). Sensitivity analysis was performed excluding participants with positive households. R, version 3.6.1 (R Foundation for Statistical Analysis) was used for statistical analysis; 2-sided, unpaired P values <.05 were considered significant. This report follows STROBE reporting guideline for observational studies.

Results

We included 2919 HCWs (median age, 43 years (range, 18-73 years); 749 participants (26%) were infected with SARS-CoV-2. SARS-CoV-2 positivity was 13% in HCWs without patient exposure. For those exposed to patients, positivity was 21% for HCWs using respirator masks and 35% for those using surgical/mixed masks (OR, 0.49; 95% CI, 0.39-0.61), showing an increase for surgical/mixed mask users (OR, 1.21; 95% CI, 1.15-1.28) and respirator mask users (OR, 1.15; 95% CI, 1.05-1.27) across categories of patient exposure (Figure). Variables associated with SARS-CoV-2 infection in multivariable analysis included a positive household contact (OR, 7.79; 95% CI, 5.98-10.15), exposure to patients (OR, 1.20 per category of cumulative contact; 95% CI, 1.14-1.26), respirator use (OR, 0.56; 95% CI, 0.43-0.74), and SARS-CoV-2 vaccination (OR, 0.55; 95% CI, 0.41-0.74) (Table). Similar results were obtained in sensitivity analysis.
Figure.

SARS-CoV-2 Positivity in Health Care Workers Depending on Cumulative Patient Exposure and Mask Type

Incidence of SARS-CoV-2 in health care workers depending on cumulative patient exposure during 12 months. Dashed line indicates SARS-CoV-2 positivity in participants without patient contact. Error bars indicate 95% CIs.

Table.

Participant Characteristics by SARS-CoV-2 Status and Results of Logistic Regression Analyses Regarding SARS-CoV-2 Risk

VariableSARS-CoV-2 status, No. (%)Univariable analysisaMultivariable analysisa
Negative (n = 2170)Positive (n = 749)OR (95% CI)P valueOR (95% CI)P value
Baseline
Age, median (range), y43.2 (18-73)40.6 (18-66)0.98 (0.97-0.99)<.0010.99 (0.98-1.01).35
BMI, median (range)24.4 (14.3-65.8)24.3 (15.8-44.6)1.00 (0.98-1.01).621.00 (0.98-1.03).75
Sex
Female1701 (78.4)597 (79.7)0.96 (0.78-1.18).690.76 (0.57-1.00).05
Male469 (21.6)152 (20.3)[Reference]
Pregnancy46 (2.1)25 (3.3)1.52 (0.92-2.51).100.64 (0.34-1.20).16
Active smoker (vs never/former)323 (14.9)77 (10.3)0.68 (0.52-0.88).0040.68 (0.49-0.95).02
At least 1 comorbidity898 (41.4)298 (39.8)0.96 (0.81-1.14).621.02 (0.82-1.27).85
Work-related factors
Cumulative patient contact (OR per category), h
0720 (33.2)110 (14.7)1.22 (1.18-1.26)<.0011.20 (1.14-1.26)<.001
>0-1230 (10.6)59 (7.9)
>1-2150 (6.9)45 (6.0)
>2-4189 (8.7)63 (8.4)
>4-8198 (9.1)79 (10.5)
>8-16212 (9.8)104 (13.9)
>16-32218 (10.0)105 (14.0)
>32-64135 (6.2)96 (12.8)
>64118 (5.4)88 (11.7)
Always respirator (vs surgical/mixed mask use)b506 (23.3)132 (17.6)0.57 (0.45-0.73)<.0010.56 (0.43-0.74)<.001
Working ≥80% FTE1130 (52.1)430 (57.4)1.30 (1.07-1.50).0071.39 (1.10-1.77).006
Working in intensive care189 (8.7)67 (8.9)1.05 (0.78-1.41).750.82 (0.57-1.16).26
Hospital canteen visit once weekly or more (vs less)1418 (65.3)490 (65.4)1.01 (0.85-1.21).881.15 (0.91-1.45).23
Nonwork-related factors
SARS-CoV-2 vaccination1915 (88.2)577 (77.0)0.49 (0.39-0.60)<.0010.55 (0.41-0.74)<.001
Positive household contact165 (7.6)314 (41.9)8.82 (7.09-11.0)<.0017.79 (5.98-10.15)<.001
Always wearing a mask outside work162 (7.5)69 (9.2)1.25 (0.93-1.68).151.33 (0.91-1.93).14

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); FTE, full-time equivalent; OR, odds ratio.

Generalized mixed-effects model (with logit link) using health care network as random effect.

In contact with patients with COVID-19 outside of aerosol-generating procedures.

SARS-CoV-2 Positivity in Health Care Workers Depending on Cumulative Patient Exposure and Mask Type

Incidence of SARS-CoV-2 in health care workers depending on cumulative patient exposure during 12 months. Dashed line indicates SARS-CoV-2 positivity in participants without patient contact. Error bars indicate 95% CIs. Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); FTE, full-time equivalent; OR, odds ratio. Generalized mixed-effects model (with logit link) using health care network as random effect. In contact with patients with COVID-19 outside of aerosol-generating procedures.

Discussion

In this study, SARS-CoV-2 positivity in HCWs was associated with cumulative COVID-19 patient exposure. The odds of being SARS-CoV-2–positive were reduced by more than 40% in individuals using respirators irrespective of cumulative exposure, even after adjusting for multiple work- and nonwork-related covariables. These data suggest a dose-response association between COVID-19-patient exposure and risk of SARS-CoV-2 infection in HCWs. The presumable protection conferred by respirator use is in line with previous data.[1,4] Self-reporting of preferred mask type and residual confounding are potential study limitations. Consequent use of respirators and SARS-CoV-2 vaccination might substantially decrease the work-related risk for HCWs exposed to patients with COVID-19. Whether these results are applicable to newer viral variants, which are more contagious and less neutralized by most vaccines,[6] remains to be seen.
  5 in total

1.  Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.

Authors:  Christian R Kahlert; Raphael Persi; Sabine Güsewell; Thomas Egger; Onicio B Leal-Neto; Johannes Sumer; Domenica Flury; Angela Brucher; Eva Lemmenmeier; J Carsten Möller; Philip Rieder; Reto Stocker; Danielle Vuichard-Gysin; Benedikt Wiggli; Werner C Albrich; Baharak Babouee Flury; Ulrike Besold; Jan Fehr; Stefan P Kuster; Allison McGeer; Lorenz Risch; Matthias Schlegel; Andrée Friedl; Pietro Vernazza; Philipp Kohler
Journal:  Clin Microbiol Infect       Date:  2021-05-18       Impact factor: 8.067

2.  Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study.

Authors:  Romain Martischang; Anne Iten; Isabelle Arm; Mohamed Abbas; Benjamin Meyer; Sabine Yerly; Isabella Eckerle; Jacques Pralong; Julien Sauser; Jean-Claude Suard; Laurent Kaiser; Didier Pittet; Stephan Harbarth
Journal:  Infect Control Hosp Epidemiol       Date:  2021-03-19       Impact factor: 3.254

Review 3.  P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects.

Authors:  Breanne Kunstler; Skye Newton; Hayley Hill; John Ferguson; Phillipa Hore; Brett G Mitchell; Kathy Dempsey; Andrew J Stewardson; Deborah Friedman; Kate Cole; Malcolm R Sim; Bridget Ferguson; Penelope Burns; Nicole King; Steven McGloughlin; Melanie Dicks; Sally McCarthy; Barry Tam; Briony Hazelton; Cherylynn McGurgan; Steve McDonald; Tari Turner
Journal:  Infect Dis Health       Date:  2022-01-20

4.  Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort.

Authors:  Christian R Kahlert; Philipp Kohler; Sabine Haller; Sabine Güsewell; Thomas Egger; Giulia Scanferla; Reto Thoma; Onicio B Leal-Neto; Domenica Flury; Angela Brucher; Eva Lemmenmeier; J Carsten Möller; Philip Rieder; Markus Rütti; Reto Stocker; Danielle Vuichard-Gysin; Benedikt Wiggli; Ulrike Besold; Stefan P Kuster; Allison McGeer; Lorenz Risch; Matthias Schlegel; Andrée Friedl; Pietro Vernazza
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-05       Impact factor: 4.887

5.  Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.

Authors:  Kasper Iversen; Henning Bundgaard; Rasmus B Hasselbalch; Jonas H Kristensen; Pernille B Nielsen; Mia Pries-Heje; Andreas D Knudsen; Casper E Christensen; Kamille Fogh; Jakob B Norsk; Ove Andersen; Thea K Fischer; Claus Antonio Juul Jensen; Margit Larsen; Christian Torp-Pedersen; Jørgen Rungby; Sisse B Ditlev; Ida Hageman; Rasmus Møgelvang; Christoffer E Hother; Mikkel Gybel-Brask; Erik Sørensen; Lene Harritshøj; Fredrik Folke; Curt Sten; Thomas Benfield; Susanne Dam Nielsen; Henrik Ullum
Journal:  Lancet Infect Dis       Date:  2020-08-03       Impact factor: 25.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.